Difference between revisions of "Coagulopathy (main)"
(→Managment) |
(→Managment) |
||
| Line 12: | Line 12: | ||
**[[Rivaroxaban reversal]] | **[[Rivaroxaban reversal]] | ||
**[[Unfractionated heparin reversal]] | **[[Unfractionated heparin reversal]] | ||
| + | *[[Anti-platelet agent reversal]] | ||
==See Also== | ==See Also== | ||
Revision as of 23:39, 27 May 2016
Contents
Differential Diagnosis
Coagulopathy
Platelet Related
- Too few
- Nonfunctional
Factor Related
- Acquired (Drug Related)
- Warfarin (Coumadin)
- Unfractionated heparin
- Low molecular weight heparin (i.e. enoxaparin (Lovenox), dalteparin)
- Factor Xa Inhibitors (e.g. rivaroxaban, apixaban, fondaparinux, edoxaban)
- Direct thrombin inhibitors (e.g. dabigatran, argatroban, bivalirudin)
- Illness induced
- Genetic
Increased Clotting
Managment
- Bleeding Treatments
- Procedures in patients with coagulopathies
- Anticoagulant reversal (known medications)
- Anti-platelet agent reversal